82_FR_45008 82 FR 44823 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

82 FR 44823 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 185 (September 26, 2017)

Page Range44823-44823
FR Document2017-20494

Federal Register, Volume 82 Issue 185 (Tuesday, September 26, 2017)
[Federal Register Volume 82, Number 185 (Tuesday, September 26, 2017)]
[Notices]
[Page 44823]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-20494]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Institute 
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; Mentored Career Development 
(K) and Conference (R13) Award Application Review (2018/01).
    Date: October 20, 2017.
    Time: 9:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: John P. Holden, Ph.D., Scientific Review 
Officer, National Institutes of Health, National Institute of 
Biomedical Imaging and Bioengineering, Bethesda, MD 20892, 301-496-
8947, [email protected].

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel; MSM Program Review (2018/01).
    Date: November 2, 2017.
    Time: 10:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Manana Sukhareva, Ph.D., Scientific Review 
Officer, National Institute of Biomedical Imaging and 
Bioengineering, National Institutes of Health, 6707 Democracy 
Boulevard, Suite 959, Bethesda, MD 20892, (301) 451-3397, 
[email protected].


    Dated: September 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20494 Filed 9-25-17; 8:45 am]
 BILLING CODE 4140-01-P



                               Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices                                                44823

     (Catalogue of Federal Domestic Assistance               DEPARTMENT OF HEALTH AND                              DEPARTMENT OF HEALTH AND
     Program Nos. 93.859, Pharmacology,                      HUMAN SERVICES                                        HUMAN SERVICES
     Physiology, and Biological Chemistry
     Research; 93.350, B—Cooperative                         National Institutes of Health
     Agreements; 93.859, Biomedical Research
                                                                                                                   National Institutes of Health
     and Research Training, National Institutes of           National Institute of Biomedical
     Health, HHS)                                                                                                  National Heart, Lung, and Blood
                                                             Imaging and Bioengineering; Notice of                 Institute; Notice of Closed Meetings
       Dated: September 20, 2017.                            Closed Meeting
     David Clary,                                                                                                    Pursuant to section 10(d) of the
     Program Analyst, Office of Federal Advisory               Pursuant to section 10(d) of the                    Federal Advisory Committee Act, as
     Committee Policy.                                       Federal Advisory Committee Act, as                    amended, notice is hereby given of the
     [FR Doc. 2017–20486 Filed 9–25–17; 8:45 am]             amended, notice is hereby given of a                  following NHLBI Special Emphasis
     BILLING CODE 4140–01–P                                  meeting of the National Institute of                  Panel meetings.
                                                             Biomedical Imaging and Bioengineering
                                                             Special Emphasis Panel.                                 The meetings will be closed to the
     DEPARTMENT OF HEALTH AND                                  The meetings will be closed to the                  public in accordance with the
     HUMAN SERVICES                                          public in accordance with the                         provisions set forth in sections
                                                             provisions set forth in sections                      552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
     National Institutes of Health                           552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            as amended. The grant applications and
                                                             as amended. The grant applications and                the discussions could disclose
     National Heart, Lung, and Blood                         the discussions could disclose                        confidential trade secrets or commercial
     Institute; Notice of Closed Meeting                                                                           property such as patentable material,
                                                             confidential trade secrets or commercial
       Pursuant to section 10(d) of the                      property such as patentable material,                 and personal information concerning
     Federal Advisory Committee Act, as                      and personal information concerning                   individuals associated with the grant
     amended, notice is hereby given of a                    individuals associated with the grant                 applications, the disclosure of which
     meeting of the NHLBI Mentored                           applications, the disclosure of which                 would constitute a clearly unwarranted
     Transition to Independence Review                       would constitute a clearly unwarranted                invasion of personal privacy.
     Committee.                                              invasion of personal privacy.                           Name of Committee: National Heart, Lung,
       The meeting will be closed to the                       Name of Committee: National Institute of            and Blood Institute Special Emphasis Panel;
     public in accordance with the                           Biomedical Imaging and Bioengineering                 Novel Bioengineering Methods/Approaches
     provisions set forth in sections                        Special Emphasis Panel; Mentored Career               for Heart, Lung, Blood, and Sleep Disorders
     552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,              Development (K) and Conference (R13)                  and Diseases.
     as amended. The grant applications and                  Award Application Review (2018/01).                     Date: October 26–27, 2017.
     the discussions could disclose                            Date: October 20, 2017.                               Time: 3:30 p.m. to 2:30 p.m.
     confidential trade secrets or commercial                  Time: 9:30 a.m. to 5:00 p.m.                          Agenda: To review and evaluate grant
     property such as patentable material,                     Agenda: To review and evaluate grant                applications.
                                                             applications.
     and personal information concerning                                                                             Place: The William F. Bolger Center, 9600
                                                               Place: National Institutes of Health, Two
     individuals associated with the grant                   Democracy Plaza, Suite 920, 6707 Democracy            Newbridge Drive, Potomac, MD 20854.
     applications, the disclosure of which                   Boulevard, Bethesda, MD 20892 (Virtual                  Contact Person: Giuseppe Pintucci, Ph.D.,
     would constitute a clearly unwarranted                  Meeting).                                             Scientific Review Officer, Office of Scientific
     invasion of personal privacy.                             Contact Person: John P. Holden, Ph.D.,              Review/DERA, National Heart, Lung, and
       Name of Committee: Heart, Lung, and                   Scientific Review Officer, National Institutes        Blood Institute, 6701 Rockledge Drive, Room
     Blood Initial Review Group; NHLBI                       of Health, National Institute of Biomedical           7192, Bethesda, MD 20892, 301–435–0287,
     Mentored Transition to Independence                     Imaging and Bioengineering, Bethesda, MD              Pintuccig@nhlbi.nih.gov.
     Review Committee.                                       20892, 301–496–8947, john.holden@nih.gov.               Name of Committee: National Heart, Lung,
       Date: November 2–3, 2017.                               Name of Committee: National Institute of            and Blood Institute Special Emphasis Panel;
       Time: 8:00 a.m. to 1:00 p.m.                          Biomedical Imaging and Bioengineering                 Career Development Consortium in
       Agenda: To review and evaluate grant                  Special Emphasis Panel; MSM Program
                                                                                                                   Glycosciences.
     applications.                                           Review (2018/01).
       Place: The William F. Bolger Center, 9600                                                                     Date: November 3, 2017.
                                                               Date: November 2, 2017.
     Newbridge Drive, Potomac, MD 20854.                       Time: 10:00 a.m. to 6:00 p.m.                         Time: 12:30 p.m. to 3:30 p.m.
       Contact Person: Giuseppe Pintucci, Ph.D.,               Agenda: To review and evaluate grant                  Agenda: To review and evaluate grant
     Scientific Review Officer, Office of Scientific         applications.                                         applications.
     Review/DERA, National Heart, Lung, and                    Place: National Institutes of Health, Two             Place: National Institutes of Health, 6701
     Blood Institute, 6701 Rockledge Drive, Room             Democracy Plaza, Suite 920, 6707 Democracy            Rockledge Drive, Room 7194, Bethesda, MD
     7192, Bethesda, MD 20892, 301–435–0287,                 Boulevard, Bethesda, MD 20892 (Virtual                20892 (Telephone Conference Call).
     Pintuccig@nhlbi.nih.gov.                                Meeting).                                               Contact Person: Charles Joyce, Ph.D.,
     (Catalogue of Federal Domestic Assistance                 Contact Person: Manana Sukhareva, Ph.D.,            Acting Chief, Office of Scientific Review/
     Program Nos. 93.233, National Center for                Scientific Review Officer, National Institute         DERA, National Heart, Lung, and Blood
     Sleep Disorders Research; 93.837, Heart and             of Biomedical Imaging and Bioengineering,
                                                                                                                   Institute, National Institutes of Health, 6701
     Vascular Diseases Research; 93.838, Lung                National Institutes of Health, 6707
     Diseases Research; 93.839, Blood Diseases                                                                     Rockledge Drive, Room 7194, Bethesda, MD
                                                             Democracy Boulevard, Suite 959, Bethesda,
     and Resources Research, National Institutes             MD 20892, (301) 451–3397, sukharem@                   20892–7924, 301–827–7939, cjoyce@
     of Health, HHS)                                         nih.gov.                                              nhlbi.nih.gov.
                                                                                                                   (Catalogue of Federal Domestic Assistance
       Dated: September 20, 2017.                              Dated: September 19, 2017.
                                                                                                                   Program Nos. 93.233, National Center for
     Michelle Trout,                                         David Clary,                                          Sleep Disorders Research; 93.837, Heart and
     Program Analyst, Office of Federal Advisory             Program Analyst, Office of Federal Advisory           Vascular Diseases Research; 93.838, Lung
     Committee Policy.                                       Committee Policy.                                     Diseases Research; 93.839, Blood Diseases
     [FR Doc. 2017–20488 Filed 9–25–17; 8:45 am]             [FR Doc. 2017–20494 Filed 9–25–17; 8:45 am]           and Resources Research, National Institutes
     BILLING CODE 4140–01–P                                  BILLING CODE 4140–01–P                                of Health, HHS)



VerDate Sep<11>2014   18:28 Sep 25, 2017   Jkt 241001   PO 00000   Frm 00065   Fmt 4703   Sfmt 4703   E:\FR\FM\26SEN1.SGM   26SEN1



Document Created: 2017-09-26 02:48:22
Document Modified: 2017-09-26 02:48:22
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesOctober 20, 2017.
FR Citation82 FR 44823 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR